Formycon AG at it's AGM elected Dr. Thomas Strüngmann to the Supervisory Board and Dr. Andreas Seidl, the future Chief Scientific Officer (CSO), who was appointed to the Management Board by the Supervisory Board effective July 01, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.3 EUR | +4.60% |
|
+13.08% | -7.27% |
Jun. 18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
Jun. 13 | Formycon Starts Clinical Trials of Keytruda Biosimilar Candidate for Skin Cancer Therapy | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.27% | 987M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- FYB Stock
- News Formycon AG
- Formycon AG Announces Supervisory Board and Executive Changes